We started Power when my dad was diagnosed with multiple myeloma, and I struggled to help him access the latest immunotherapy. Hopefully Power makes it simpler for you to explore promising new treatments, during what is probably a difficult time.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Condition
Location
By Condition
By Location
By Subject
By Trial
Search Clinical Trials
Conditions
Locations
Treatment Type
Trial Phase
Trial Status
Paid Participation
Trial Details
Key Eligibility Criteria
900 Participants Needed
Trial Details
Key Eligibility Criteria
330 Participants Needed
Trial Details
Key Eligibility Criteria
118 Participants Needed
Trial Details
Key Eligibility Criteria
550 Participants Needed
Trial Details
Key Eligibility Criteria
220 Participants Needed
Trial Details
Key Eligibility Criteria
150 Participants Needed
Trial Details
Key Eligibility Criteria
120 Participants Needed
Trial Details
Key Eligibility Criteria
316 Participants Needed
Trial Details
Key Eligibility Criteria
214 Participants Needed
Trial Details
Key Eligibility Criteria
207 Participants Needed
Trial Details
Key Eligibility Criteria
428 Participants Needed
Trial Details
Key Eligibility Criteria
1123 Participants Needed
Trial Details
Key Eligibility Criteria
959 Participants Needed
Trial Details
Key Eligibility Criteria
976 Participants Needed
Trial Details
Key Eligibility Criteria
994 Participants Needed
Trial Details
Key Eligibility Criteria
462 Participants Needed
Trial Details
Key Eligibility Criteria
450 Participants Needed
Trial Details
Key Eligibility Criteria
738 Participants Needed
Trial Details
Key Eligibility Criteria
907 Participants Needed
Trial Details
Key Eligibility Criteria
408 Participants Needed
"I wasn’t diagnosed until February, but I showed symptoms over ten years before. I want to help find a cure. I have lost family members to Parkinson’s and want to contribute to the search for better treatments before my children possibly come down with it."
"I have 5 kids. I'll do anything I can to slow this disease down in hopes that I can stay active with them into their adulthood. I also feel I am serving the greater good for all those who suffer from Parkinson's. Since I'm self employed, my schedule is flexible. "
"My dad was in a research group for Parkinson's for about 6 years, which was very interesting. I was just diagnosed 1.5 years ago, and started on low dose Sinemet. Doing well on Sinemet, but I'd like to get ahead of the condition. I'm excited about participating in research. "
"It seems my Parkinson’s is progressing more rapidly now. And my meds are lagging behind. My off time is more frequent and the episodes are longer. Trying to figure out what my options are."
"I changed my diet in 2020 and I’ve lost 95 pounds from my highest weight (283). I am 5’3”, female, and now 188. I still have a 33 BMI. I've been doing research on alternative approaches to continue my progress, which brought me here to consider clinical trials."
Trial Details
Key Eligibility Criteria
703 Participants Needed
Trial Details
Key Eligibility Criteria
89 Participants Needed
Know someone looking for new options?
Spread the word
Each trial will compensate patients a different amount, but $50-100 for each visit is a fairly common range for Phase 2–4 trials (Phase 1 trials often pay substantially more). Further, most trials will cover the costs of a travel to-and-from the clinic.
After a researcher reviews your profile, they may choose to invite you in to a screening appointment, where they'll determine if you meet 100% of the eligibility requirements. If you do, you'll be sorted into one of the treatment groups, and receive your study drug. For some trials, there is a chance you'll receive a placebo. Across Parkinson's Disease trials in Oklahoma 30% of clinical trials have a placebo. Typically, you'll be required to check-in with the clinic every month or so. The average trial length in Oklahoma for Parkinson's Disease is 12 months.
Not all studies recruit healthy volunteers: usually, Phase 1 studies do. Participating as a healthy volunteer means you will go to a research facility in Oklahoma several times over a few days or weeks to receive a dose of either the test treatment or a "placebo," which is a harmless substance that helps researchers compare results. You will have routine tests during these visits, and you'll be compensated for your time and travel, with the number of appointments and details varying by study.
The phase of a trial reveals what stage the drug is in to get approval for a specific condition. Phase 1 trials are the trials to collect safety data in humans. Phase 2 trials are those where the drug has some data showing safety in humans, but where further human data is needed on drug effectiveness. Phase 3 trials are in the final step before approval. The drug already has data showing both safety and effectiveness. As a general rule, Phase 3 trials are more promising than Phase 2, and Phase 2 trials are more promising than phase 1.
Clinical trials are almost always free to participants, and so do not require insurance. The only exception here are trials focused on cancer, because only a small part of the typical treatment plan is actually experimental. For these cancer trials, participants typically need insurance to cover all the non-experimental components.
Most recently, we added Prasinezumab for Parkinson's Disease, BHV-8000 for Parkinson's Disease and Sacituzumab Tirumotecan + Pembrolizumab for Endometrial Cancer to the Power online platform.